These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 3438322)

  • 1. [Single-step preparations of 2-alkoxy(phenoxy)-4H-3,1-benzoxazine-4-ones inhibiting chymotrypsin].
    Leistner S; Simon R; Wagner G; Stürze-Becher J
    Pharmazie; 1987 Oct; 42(10):694-5. PubMed ID: 3438322
    [No Abstract]   [Full Text] [Related]  

  • 2. [Biologically active N-Mannich bases of 2,3-dioxo-1,4-benzoxazine].
    Movrin M; Mladar MJ
    Pharmazie; 1983 Dec; 38(12):883-5. PubMed ID: 6669620
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhibition of chymotrypsin and pancreatic elastase by 4H-3,1-benzoxazin-4-ones.
    Neumann U; Stürzebecher J; Leistner S; Vieweg H
    J Enzyme Inhib; 1991; 4(3):227-32. PubMed ID: 2037867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [2-ethylamino-6-chloro-4-methyl-4-phenyl-4H-3,1-benzoxazine, a new psychotropic compound].
    Hoffmann I; Kuch H; Schmitt K; Seidl G
    Arzneimittelforschung; 1970 Jul; 20(7):975. PubMed ID: 5536073
    [No Abstract]   [Full Text] [Related]  

  • 5. An efficient route to 3-aryl-substituted quinolin-2-one and 1,8-naphthyridin-2-one derivatives of pharmaceutical interest.
    Mitsos CA; Zografos AL; Igglessi-Markopoulou O
    J Org Chem; 2003 May; 68(11):4567-9. PubMed ID: 12762773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Syntheses of 3,4-dihydro-2H-1,4-benzoxazine-2-acetates and related compounds.
    Masuoka Y; Asako T; Goto G; Noguchi S
    Chem Pharm Bull (Tokyo); 1986 Jan; 34(1):130-9. PubMed ID: 2870815
    [No Abstract]   [Full Text] [Related]  

  • 7. [Reaction of 3-aryl-2-nitroacrylates with titanium tetrachloride. Formation of 4H-1,2-oxazines and hydroxy-arylaldehydes].
    Hirotani S; Zen S
    Yakugaku Zasshi; 1994 Apr; 114(4):272-6. PubMed ID: 8201549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [3-Dialkylamino-substituted 2H-1,4-benzoxazines].
    Balbi A; Ferreccio R; Mazzei M; Ermili A; Roma G
    Farmaco Sci; 1986 Dec; 41(12):942-53. PubMed ID: 3556568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of hexahydro-1,4-oxazepine derivatives with expected pharmacological activity. VI. -Homomorpholinoethyl and -morpholinoethyl phenoxy- and halophenoxyacetates.
    Kotelko B; Rokita T
    Acta Pol Pharm; 1972; 29(4):365-71. PubMed ID: 4652506
    [No Abstract]   [Full Text] [Related]  

  • 10. [Synthesis, conformation and pharmacological effect of some stereoisomeric condensed 1,3-oxazine-4-ones. 44: Stereochemical studies; 22: Saturated heterocycles].
    Bernáth G; Fülöp F; Ecsery Z; Blazsó G; Minker E
    Pharmazie; 1983 Feb; 38(2):89-92. PubMed ID: 6602344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Synthesis of potential biologically active benzotheno-oxazinones].
    Oremek G; Seiffert U; Siede W
    Pharmazie; 1984 Aug; 39(8):574-5. PubMed ID: 6504985
    [No Abstract]   [Full Text] [Related]  

  • 12. Triazines and related products. 8. Potential irreversible chymotrypsin inhibitors: 3-alkyl-1,2,3-benzotriazin-4(3H)-ones and o-azidobenzamides.
    Mair AC; Stevens MF
    J Chem Soc Perkin 1; 1971; 12():2317-24. PubMed ID: 5104591
    [No Abstract]   [Full Text] [Related]  

  • 13. Synthesis of new 2-arylidene-2H-1,4-benzoxazin-3(4H)-ones.
    Gezginci H; Salman S; Okyar A; Baktir G
    Farmaco; 1997 Apr; 52(4):255-6. PubMed ID: 9241832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of inactivation of chymotrypsin by 5-butyl-3H-1,3-oxazine-2,6-dione.
    Weidmann B; Abeles RH
    Biochemistry; 1984 May; 23(11):2373-6. PubMed ID: 6548151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Derivatives of 2-amino-1,2,3,4-tetrahydronaphthalene. XI: trans-6,9-dimethoxy-2,3,4a,5,10,10a-hexahydro-4H-naphth[2,3-b]1, 4-oxazines--tricyclic analogs trans-2-amino-3-hydroxy-5,8-dimethoxytetralins.
    Troanska G; Christova K; Danchev D
    Arch Pharm (Weinheim); 1987 Jul; 320(7):625-9. PubMed ID: 2890334
    [No Abstract]   [Full Text] [Related]  

  • 16. New compounds: 4-substituted 5,6-dihydro-2-o-hydroxyphenyl-4H-1,3,4-oxadiazine-5-ones, potential psychopharmacological drugs.
    Sicardi SM; Lamdan S; Gaozza CH
    J Pharm Sci; 1974 Aug; 63(8):1336-7. PubMed ID: 4853339
    [No Abstract]   [Full Text] [Related]  

  • 17. Novel thieno[2,3-d][1,3]oxazin-4-ones as inhibitors of human leukocyte elastase.
    Gütschow M; Neumann U
    J Med Chem; 1998 May; 41(10):1729-40. PubMed ID: 9572899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Synthesis and pharmacological studies of new 1,4,7-oxadiazonine and 1,5,6-oxadiazonine derivatives].
    Mikiciuk-Olasik E; Glinka R; Kotełko B; Szadowska A; Kiełek MB
    Acta Pol Pharm; 1984; 41(1):49-54. PubMed ID: 6541859
    [No Abstract]   [Full Text] [Related]  

  • 19. Suicide enzyme inactivators.
    Abeles RH
    Basic Life Sci; 1983; 25():287-305. PubMed ID: 6602608
    [No Abstract]   [Full Text] [Related]  

  • 20. 2-amino-4H-3,1-benzoxazin-4-ones as inhibitors of C1r serine protease.
    Hays SJ; Caprathe BW; Gilmore JL; Amin N; Emmerling MR; Michael W; Nadimpalli R; Nath R; Raser KJ; Stafford D; Watson D; Wang K; Jaen JC
    J Med Chem; 1998 Mar; 41(7):1060-7. PubMed ID: 9544206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.